Background and Aims: Subarachnoid hemorrhage is sudden bleeding in the subarachnoid space, representing 5–10% of strokes. Several reports of Covid-19 infection and subarachnoid hemorrhage have been published. The objective of the study was to analyze subarachnoid hemorrhage in patients with COVID 19. Methods: A retrospective study of all electronic medical records of patients with COVID 19 treated in the Institute of Neurology and Neurosurgery between March 2020 and May 2021, from 204 patients 7 with subarachnoid hemorrhage was identified. Results: The study sample includes 3 men (42.9%) and 4 women (57.1) with altered mental state, convulsions, severe headache, nausea, and focal signs at the presentation. In one patient hemorrhage occurred 4 days after Covid-19 detection; for 5 patients the infection and hemorrhage were confirmed at admission, and 1 patient is diagnosed with SARS – Cov-2 during hospitalization. There was a marked increase in inflammatory markers (leukocytosis, increased ESR), the presence of pulmonary lesions in 8 pts. Angio CT revealed the presence of aneurysms in 5 patients. Most underwent surgery: by clipping – 6 patients, embolization of the anterior communicating artery -1 pts and one attempt to ligate the left internal carotid artery. Out of 7 patients - 3 died and 4 were treated. Conclusions: In our case series, subarachnoid hemorrhage occurs both at the initial stage of COVID 19 infection and later after treatment. The association of infection in patients with subarachnoid hemorrhage leads to pulmonary involvement with inflammatory response and worsening of neurological status with poor prognosis.